Singaporean cultivated seafood producer UMAMI Bioworks has signed a Memorandum of Understanding (MoU) with Nippon Barrier ...

Find all Nippon Barrier Free news in chronological order with our extensive archive and stay informed on Nippon Barrier Free and the vegan, plant-based and cellular agriculture market.

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced its results for the third quarter ended September 30, 2025. The update, including a webcast slide presentation with additional ...

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares continue to trade higher after rising nearly 10% on Tuesday. Here’s a look at what’s going on. What To Know: Ginkgo Bioworks shares appear to be getting ...

In the latest close session, Ginkgo Bioworks Holdings, Inc. (DNA) was up +1.96% at $8.31. The stock's change was more than the S&P 500's daily loss of 0.74%. On the other hand, the Dow registered a ...

Could Ginkgo Bioworks Holdings (NYSE: DNA) one day be part of the healthcare sector's version of the "Magnificent Seven" group of high-performing stocks? It's more likely than you think. The ...

Detailed price information for Ginkgo Bioworks Hldgs Inc (DNA-N) from The Globe and Mail including charting and trades.

Ginkgo's future may be promising, but whether the company can realize its potential is debatable. Special purpose acquisition companies (SPACs) were popular in 2021 while investors were buying up meme ...

Through biological engineering, Ginkgo Bioworks design custom organisms to create new products with the potential to transform industries. Today the company announced the Series E financing round ...

Ginkgo Bioworks is aiming to play a key role in drug development. And there's a solid argument for why it could be hugely successful one day. But it'll need to become a lot more efficient as it scales ...